Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_assertion description "[Additionally, in LDL receptor null mice after influenza infection, D-4F treatment increased plasma HDL levels and paraoxonase activity, and inhibited increased in LDL-cholesterol and peak levels of interleukin-6 post-infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_assertion evidence source_evidence_literature NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_assertion SIO_000772 14582455 NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_assertion wasDerivedFrom befree-2016 NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_assertion wasGeneratedBy ECO_0000203 NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.
- befree-2016 importedOn "2016-02-19" NP418484.RAk-LC9WJ1qXSQc4kIYqK5dGoxx4koCyc--3JUZXkl_Tg130_provenance.